Identification | Back Directory | [Name]
CTOP | [CAS]
103429-31-8 | [Synonyms]
NTB CTOP NALTRIBEN threoninamide CYS2,TYR3,ORN5,PEN7-AMIDE M.W. 1062.26 C50H67N11O11S2 (Tyr3,Orn5,Pen7)-Octreotate amide Cys2, Tyr3, Orn5, Pen7 amide - CTOP DPHE-CYS-TYR-DTRP-ORN-THR-PEN-THR-OL D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN-THR-NH2 CTOP, (Tyr3,Orn5,Pen7)-Octreotate aMide D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN-THR AMIDE H-D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN-THR-NH2 FCYW(ORN)T(PEN)T-NH2 (DISULFIDE BRIDGE: 2-7) [Cys2, Tyr3, Orn5, Pen7-amide]-Somatostatin 14 (7-14) [CYS2, TYR3, ORN5, PEN7]-SOMATOSTATIN 14 (7-14), AMIDE D-Phe-L-Cys(1)-L-Tyr-D-Trp-L-Orn-L-Thr-L-Pen(1)-L-Thr-NH2 H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (Disulfide bond) H-D-PHE-CYS-TYR-D-TRP-ORN-THR-PEN-THR-NH2 (DISULFIDE BRIDGE: 2-7) D-Phe-L-Cys(1)-L-Tyr-D-Trp-L-Orn-L-Thr-3-Mercapto(1)-L-Val-L-Thr-NH2 phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine) H-D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2, (Disulfide bond between Cys2 and Pen7) phenylalanyl-cyclo(cysteinyltyrosyl-tryptophyl-ornithyl-threonyl-penicillamine)threoninamide L-Threoninamide, D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-ornithyl-L-threonyl-3-mercapto-L-valyl-, cyclic (2→7)-disulfide | [Molecular Formula]
C50H67N11O11S2 | [MDL Number]
MFCD00076708 | [MOL File]
103429-31-8.mol | [Molecular Weight]
1062.26 |
Chemical Properties | Back Directory | [Boiling point ]
1491.2±65.0 °C(Predicted) | [density ]
1.42±0.1 g/cm3(Predicted) | [RTECS ]
XO8578200 | [storage temp. ]
-20°C | [form ]
Powder | [pka]
9.90±0.15(Predicted) | [Water Solubility ]
Soluble to 1 mg/ml in water |
Hazard Information | Back Directory | [Uses]
CTOP has been used:
- to study the anxiogenic effects induced by CTOP in mice and rat.
- to study the effect of μ-opioid antagonist, CTOP on the bovine milk-derived LF (BLF)-induced analgesia.
- to determine whether μ-opioid receptors act cooperatively with 5-hydroxytryptamine (5-HT1A) receptors to regulate the behaviors generated in the elevated T-maze (ETM).
| [Uses]
CTOP is a μ-opioid receptor antagonist which has been shown to regulate behaviour and expression in rats. An endogenous opioid peptide which may also be used in the treatment of pain through improved morphine tolerance via blocking of mTOR. | [General Description]
D-Pen-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) is a selective cyclic μ-opioid receptor antagonist. | [Biochem/physiol Actions]
Selective ligand for μ-opioid receptors. | [storage]
Store at -20°C |
|
|